Current Issue
Advanced Therapy Medicinal Products Technology Transfer Challenges – Part 3
Robert Dream, Managing Director, HDR Company LLC
Advances and Challenges in Vaccine Development and Manufacture
Tony D’Amore, Ph.D. MBA, Board Member, Scientific Advisor and Independent Consultant for...
Endotoxin Control Strategies for Parenteral Drug Product Manufacturing
Robert Simler, Associate Vice President, Process Development, Amgen (previously Associate ...
Current Trends in Control and Monitoring of Subvisible Particulate Matter in Biotherapeuti...
Satish (Kumar) Singh, Vice President, Drug Product Development, Astria Therapeutics, Inc. ...
Lifetime Study for JSR Amsphere A3 – Protein A Resin
JSR Life Sciences
Featured Articles
Successful Wetting for Filter Integrity Testing in Volume-Restricted Systems
Benefits of Mixed-Mode Cation Exchange Chromatography: CMM HyperCel™ Sorbent Used for Monoclonal Antibody and Other Recombinant Protein Purification
Volume Reduction and Process Optimization with Cadence Inline Concentrator
Characterization and Engineering Performance of the Allegro™ STR 500 Single-Use Stirred Tank Bioreactor
View All Featured ArticlesHeadline News
Eli Lilly finalizes purchase of AtaiBeckley, expanding its pipeline for treatment-resistant depression and other mental health conditions
Roche partner MediLink reports Phase III data showing Tam-Peli significantly extends survival in Chinese small-cell lung cancer patients
Tagrisso shows unprecedented eight-year survival benefit in early-stage EGFR-mutated lung cancer in ADAURA trial
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
Commercial Cell Therapy Experience Using Mycoplasma NAT For Product Release: Five-Year Review
Presented by John Duguid, Executive Director, Research & Development at Vericel Corporation and Lori Daane, Pharma Microbiology Sr. Scientific Director at bioMérieux and Mike Brewer, Director, Global Principal Consultant, Regulatory, BioProduction at Thermo Fisher Scientific
01st November 2022
From Product Characterization to Clinical Reliable Specifications
Presented by André Mischo, Associate Director Science & Technology at Novartis
11th May 2022
Understanding the Propensity of Sequence Variants During Cell Line and Culture Process Development
Presented by Dr. Lisa Marzilli, Associate Research Fellow and group leader at Pfizer, USA
18th March 2019
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
Amsphere A3 – protein A resin: an optimized media to minimize the impact of elution buffer selection
Amsphere TM A3
Best Practices for Achieving Virus Safety
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products
